Max Rosett, Chief Financial Officer at Immunome Inc. (IMNM), sold 65,000 shares at $21.91 ($1.4M) on 2026-04-02, disclosed to the SEC on 2026-04-03.
Scheduled sale ($1.4M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.91 | 63,656 | $1.4M | 97.9% |
| 2 | $22.48 | 1,344 | $30K | 2.1% |
| Total | $21.92 avg | 65,000 | $1.4M | 100% |
| Filing → |